NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $13,000 | -23.5% | 4,749 | -67.1% | 0.00% | – |
Q4 2019 | $17,000 | +41.7% | 14,414 | +100.9% | 0.00% | – |
Q3 2019 | $12,000 | -76.9% | 7,175 | -35.7% | 0.00% | – |
Q2 2019 | $52,000 | -32.5% | 11,155 | -5.9% | 0.00% | – |
Q1 2019 | $77,000 | +755.6% | 11,856 | +578.6% | 0.00% | – |
Q4 2018 | $9,000 | -74.3% | 1,747 | -57.5% | 0.00% | – |
Q3 2018 | $35,000 | – | 4,109 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 9,741,636 | $25,718,000 | 7.00% |
HARVARD MANAGEMENT CO INC | 505,871 | $1,335,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,050,000 | $2,772,000 | 0.17% |
Maven Securities LTD | 381,150 | $1,006,000 | 0.12% |
Athanor Capital, LP | 547,651 | $1,446,000 | 0.09% |
MONETA GROUP INVESTMENT ADVISORS LLC | 102,652 | $271,000 | 0.03% |
TERRIL BROTHERS, INC. | 19,300 | $51,000 | 0.02% |
MEEDER ASSET MANAGEMENT INC | 5,878 | $15,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 94,908 | $251,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |